Literature DB >> 8111372

Enhanced expression of the murine FMR1 gene during germ cell proliferation suggests a special function in both the male and the female gonad.

D Bächner1, A Manca, P Steinbach, D Wöhrle, W Just, W Vogel, H Hameister, A Poustka.   

Abstract

To elucidate the function of the FMR1 gene, we applied RNA in situ hybridization to cryosections of mice from different developmental stages. The murine Fmr-1 was found transcribed in a ubiquitous manner with an expression pattern similar to glyceraldehyd phosphate dehydrogenase, Gapdh, which was used as a control gene. A significant difference in the Fmr-1 expression pattern, however, was markedly enhanced expression specifically confined to the testis and the fetal ovary. In the immature and mature testis an elevated level of Fmr-1 expression is found in type A1 spermatogonia. Expression in the testis is observed in fetal life, reaches the highest level in the immature testis, and declines early in adult life. In the mature ovary no specific Fmr-1 expression signal was found but enhanced levels were seen in the fetal ovary. At this developmental stage proliferation of oogonia takes place. It is suggested that FMR1 serves a special function during germ cell proliferation in males and females. These findings are discussed in the light of the current observation that fragile X patients produce only sperm with a premutation sized allele. Two hypotheses are put forward: (1) In males lack of FMR1 function results in a premeiotic defect preventing spermatogonia with a full mutation to reach meiosis. A fragile X mutation can be passed on to offsprings only as a premutation (selection hypothesis). (2) Transition of a premutation allele to full mutation occurs in a postzygotic stage after separation of the germ line and is restricted to soma cells (restriction hypothesis). Expression of FMR1 in proliferating germ cells is in line with both hypothesis.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8111372     DOI: 10.1093/hmg/2.12.2043

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  14 in total

1.  Studies of FRAXA and FRAXE in women with premature ovarian failure.

Authors:  A Murray; J Webb; S Grimley; G Conway; P Jacobs
Journal:  J Med Genet       Date:  1998-08       Impact factor: 6.318

2.  Chromosomal fragility and human genetic disorders.

Authors:  S Baskaran; V Brahmachari
Journal:  Indian J Clin Biochem       Date:  2000-08

3.  Imprinting effect in premature ovarian failure confined to paternally inherited fragile X premutations.

Authors:  R D Hundscheid; E A Sistermans; C M Thomas; D D Braat; H Straatman; L A Kiemeney; B A Oostra; A P Smits
Journal:  Am J Hum Genet       Date:  2000-02       Impact factor: 11.025

4.  Increase of FMRP expression, raised levels of FMR1 mRNA, and clonal selection in proliferating cells with unmethylated fragile X repeat expansions: a clue to the sex bias in the transmission of full mutations?

Authors:  U Salat; B Bardoni; D Wöhrle; P Steinbach
Journal:  J Med Genet       Date:  2000-11       Impact factor: 6.318

5.  CNS expression of murine fragile X protein (FMRP) as a function of CGG-repeat size.

Authors:  Anna Lisa Ludwig; Glenda M Espinal; Dalyir I Pretto; Amanda L Jamal; Gloria Arque; Flora Tassone; Robert F Berman; Paul J Hagerman
Journal:  Hum Mol Genet       Date:  2014-01-23       Impact factor: 6.150

6.  Fragile-X syndrome: genetic aspects and stomatologic evaluations.

Authors:  F Muzzi; F Santini; G Romanini; F N Bartuli; C Arcuri
Journal:  Oral Implantol (Rome)       Date:  2011-01-13

Review 7.  The FMR1 gene and fragile X-associated tremor/ataxia syndrome.

Authors:  J R Brouwer; R Willemsen; B A Oostra
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2009-09-05       Impact factor: 3.568

8.  Condensation behaviour of the human X chromosome in male germ cells and Sertoli cells examined by fluorescence in situ hybridization.

Authors:  S Kofman-Alfaro; R M Speed; S Boyle; A C Chandley
Journal:  Chromosome Res       Date:  1994-11       Impact factor: 5.239

9.  Instability of the CGG repeat and expression of the FMR1 protein in a male fragile X patient with a lung tumor.

Authors:  E de Graaff; R Willemsen; N Zhong; C E de Die-Smulders; W T Brown; G Freling; B Oostra
Journal:  Am J Hum Genet       Date:  1995-09       Impact factor: 11.025

10.  Impact of the antiproliferative agent ciclopirox olamine treatment on stem cells proteome.

Authors:  Gry H Dihazi; Asima Bibi; Olaf Jahn; Jessica Nolte; Gerhard A Mueller; Wolfgang Engel; Hassan Dihazi
Journal:  World J Stem Cells       Date:  2013-01-26       Impact factor: 5.326

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.